Drawing for GENSCRIPT SCRIPTING POSSIBILITIES

USPTO serial 79458689

GENSCRIPT SCRIPTING POSSIBILITIES

Reviewed by CopyMark Law Group

Status 640Office Action
Filing date
Status date
Registration date
—
Examiner
SHIH, SALLY
Law office
TMEG LAW OFFICE 106

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 640: Status 640 means the examining attorney has prepared a non-final Office Action but it has not been mailed or e-mailed yet. The action should appear in TSDR soon, and a response deadline will start once it is issued.

Need help with GENSCRIPT SCRIPTING POSSIBILITIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Enzyme preparations for industrial purposes; enzymes for industrial purposes; catalysts; antimicrobial agent; biochemical catalysts; diagnostic preparations, other than for medical or veterinary purposes; protein [raw material]; biological preparations, other than for medical or veterinary purposes; bacterial preparations, other than for medical and veterinary use; preparations of microorganisms, other than for medical and veterinary use; electrophoresis gels, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; enzymes for the food industry; enzymes for the brewing industry; proteins for the food industry; vitamins for use in the manufacture of pharmaceuticals.ACTIVE—
005Enzyme preparations for medical purposes; diagnostic preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes; preparations of trace elements for human and animal use; chemico-pharmaceutical preparations; chemical preparations for pharmaceutical purposes; biological preparations for medical purposes; preparations of microorganisms for medical or veterinary use; bacterial preparations for medical and veterinary use; chemical reagents for medical or veterinary purposes; diastase for medical purposes; enzyme dietary supplements; enzyme preparations for veterinary purposes; biological preparations for veterinary purposes.ACTIVE—
040Custom manufacturing of pharmaceuticals; processing and treating of chemical reagents; processing of medicinal materials; custom manufacturing of biopharmaceuticals; custom biomanufacturing of pharmaceuticals; custom manufacturing of cancer vaccines; providing information relating to material treatment; custom assembling of materials for others.ACTIVE—
042Conducting technical project studies; scientific laboratory services; technological research; research and development of new products for others; chemical research; chemistry services; cosmetic research; chemical analysis; biological research; bacteriological research; development of pharmaceutical preparations and medicines; pharmaceutical research and development services; clinical trials; structural and functional analysis of genomes; genetic testing for scientific research purposes.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 23, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 22, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 21, 2026DOCKASSIGNED TO EXAMINER—
Sep 18, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 18, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 17, 2026REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance